Argireline® is a unique new peptide, called Acetyl Hexapeptide-3, that both reduces existing facial wrinkles and is effective against the development of new wrinkles. Studies with human volunteers show that argireline delivers superior anti-wrinkle results, with the severity of wrinkles around the eyes decreased up to 17% after 15 days of treatment and up to 27% after 30 days of treatment. This represents a breakthrough in cosmetic science because of its remarkable speed in anti-wrinkle activity.

Argireline® also decreases the depth of facial wrinkles caused by the contraction of muscles from facial expressions, especially near the eyes and on the forehead. Botox® targets the same wrinkles, but Argireline® is safer and less expensive.